Inmune BioINMB 
$5.19-6.49%24h
-6.49%24h
Global rank21600
Market cap$93.53M
Change 7d-7.16%
YTD Performance-53.45%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Inmune Bio (INMB)
As of November 2024, Inmune Bio has a market cap of $93.53M. This makes Inmune Bio the world's 21600th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Inmune Bio from 2019 to 2024
-
Value:-
Market cap history of Inmune Bio from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $255.10M | 25.71% |
| 2023 | $202.92M | 77.60% |
| 2022 | $114.26M | -37.84% |
| 2021 | $183.82M | -40.77% |
| 2020 | $310.33M | 196.90% |
| 2019 | $104.53M | - |
INMB Market Cap Today is $93.53M -6.49% - 20 Nov 2024
View largest stocks by market cap 
